Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Soleno Therapeutics Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 22 | 26 | +4 |
| Shares | 3.13M | 3.03M | −98.7K (−3.2%) |
| Value | $5.23M | $6.00M | +$776.5K (+14.9%) |
New holders (6)
Institutions that held Soleno Therapeutics Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 45,876 | $91.0K | 0.00% |
| Two Sigma Securities, LLC | 19,932 | $39.5K | 0.01% |
| Ergoteles LLC | 12,570 | $24.9K | 0.00% |
| Susquehanna International Group, LLP | 11,545 | $22.9K | 0.00% |
| Citigroup Inc | 100 | $198 | 0.00% |
| Bank of America Corp | 1 | $2 | 0.00% |
Sold out (2)
Institutions that held Soleno Therapeutics Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Granite Point Capital Management, L.P. | 176,456 | $295.0K |
| BNP Paribas Arbitrage, SA | 9,333 | $15.6K |